P53 Protein Accumulation in Lung Carcinomas of Patients Exposed to Asbestos and Tobacco Smoke
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Primary lung carcinomas often carry mutations in the p53 tumor suppressor gene. Most of these mutations alter the conformation of the p53 protein into a more stable phenotype that makes it immunohistochemically detectable. Asbestos is a carcinogen that can cause deletions in chromosomes and possibly also gene mutations. In this study we examined 70 primary lung carcinomas for p53 protein accumulation using a polyclonal antihuman p53 antibody, CM-1. Patients were interviewed about their occupational and smoking history and classified according to their anamnestical asbestos exposure. Presence of asbestos bodies (AB) was evaluated from histologic samples of peripheral nontumorous lung tissue using both 5-microns-thick sections stained with Perls' iron and 30-microns-thick unstained sections. Abnormal accumulation of p53 protein was found in 36 tumors (51%), more often in patients exposed to asbestos than in patients without exposure (67% versus 40%, p = 0.027). Significant association was also noticed between the accumulation of p53 and the asbestos content of lung tissue: 35% of the p53-positive patients had more than one AB/cm2 compared with 14% of p53-negative cases (p = 0.046). Patients with strongly p53-positive tumors were heavier smokers (57.2 +/- 38.2 pack-years) than patients with p53-negative or lightly positive tumors (38.9 +/- 19.9 pack-years) (p = 0.017). Our findings indicate that both asbestos exposure and heavy smoking can cause abnormal p53 protein accumulation suggestive of mutated p53.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The levels of p53 accumulation in the respiratory epithelium of lung cancer patients with asbestosis and p53 point mutations are widely evident (Husgafvel-Pursiainen et al., 1997; Nuorva et al., 1994; Panduri et al., 2006; Topinka et al., 2004).”
From Role of Mutagenicity in Asbestos Fiber-Induced Carcinogenicity and Other Diseases (2011) · cites this paper as Nuorva et al., 1994
Citations
Cites
Practical Statistics for Medical Research
Altman, D. G. (1990) · doi:10.1201/9780429258589 · Cited by 10,668
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Increased expression of mutant forms of p53 oncogene in primary lung cancer
Iggo, R., Bartek, J., Lane, D., Gatter, K., Harris, A. L., & Bartek, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90801-b · Cited by 1,031
Asbestos Exposure, Smoking, and Neoplasia
Selikoff, I. J. (1968) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1968.03140150010003 · Cited by 695
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
MORTALITY EXPERIENCE OF INSULATION WORKERS IN THE UNITED STATES AND CANADA, 1943‐1976*
Selikoff, I. J., Hammond, E. C., & Seidman, H. (1979) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1979.tb18711.x · Cited by 586
Wild-type p53 can down-modulate the activity of various promoters.
Ginsberg, D., Mechta, F., Yaniv, M., & Oren, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9979 · Cited by 435
Embryonic lethal mutation in mice induced by retrovirus insertion into the α1(I) collagen gene
Schnieke, A., Harbers, K., & Jaenisch, R. (1983) · Nature · doi:10.1038/304315a0 · Cited by 417
Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.
Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., & Doshi, H. M. (1992) · PubMed · Cited by 383
Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
Vahakangas, K. H., Metcalf, R. A., Welsh, J. A., Bennett, W. P., Harris, C. C., Samet, J. M., & Lane, D. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90866-2 · Cited by 316
Self-citationCellular and Molecular Basis of the Asbestos-related Diseases
Rom, W. N., Travis, W. D., & Brody, A. R. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.2.408 · Cited by 252
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
Sun, X.-F., Carstensen, J. M., Stål, O., Wingren, S., Hatschek, T., Nordenskjöld, B., & Zhang, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)92558-w · Cited by 223
Maestro, R., Dolcetti, R., Gasparotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., & Boiocchi, M. (1992) · PubMed · Cited by 201
p53 and Kirsten-ras mutations in human mesothelioma cell lines.
Metcalf, R. A., Welsh, J. A., Bennett, W. P., Seddon, M. B., Lehman, T. A., Pelin, K., Linnainmaa, K., Tammilehto, L., Mattson, K. V., & Gerwin, B. I. (1992) · PubMed · Cited by 146
Bt, M., Jp, M., & Shatos, M. A. (1986) · PubMed · Cited by 127
p53 and c‐erbB‐2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder
Kamel, D., Pääkkö, P. K., Nuorva, K., Vähäkangas, K., & Soini, Y. (1993) · The Journal of Pathology · doi:10.1002/path.1711700111 · Cited by 94
Self-citationGenetic alterations of the p53 gene are a feature of malignant mesotheliomas.
Côté, R. J., Jhanwar, S. C., Novick, S., & Pellicer, À. (1991) · PubMed · Cited by 94
Westra, W. H., Offerhaus, G. J. A., Goodman, S. N., Slebos, R. J. C., Polak, M., Baas, I. O., Rodenhuis, S., & Hruban, R. H. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199303000-00001 · Cited by 91
Immunoreactivity for p53 protein in malignant mesothelioma and non‐neoplastic mesothelium
Ramael, M., Lemmens, G., Eerdekens, C., Buysse, C., Deblier, I., Jacobs, W., & Marck, E. V. (1992) · The Journal of Pathology · doi:10.1002/path.1711680406 · Cited by 83
Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA.
Appel, J. D., Fasy, T. M., Kohtz, D. S., Kohtz, J. D., & Johnson, E. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7670 · Cited by 83
Roggli, V. L., & Pratt, P. C. (1983) · Human Pathology · doi:10.1016/s0046-8177(83)80122-1 · Cited by 72
Two-Stage Carcinogenesis Studies With Asbestos in Fischer 344 Rats 2 3
Topping, D. C., & 6, P. N. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/65.3.627 · Cited by 72
Correlation of quantitative asbestos body counts and occupation in urban patients.
Churg, A., & Warnock, M. L. (1977) · PubMed · Cited by 70
Two-stage carcinogenesis studies with asbestos in Fischer 344 rats.
Topping, D. C., & Nettesheim, P. (1980) · PubMed · Cited by 65
Comparative analysis ofp53 protein immunoreactivity in prostatic, lung and breast carcinomas
Soini, Y., Pääkkö, P. K., Nuorva, K., Kamel, D., Lane, D. P., & Vähäkangas, K. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01611179 · Cited by 61
Self-citation(1985) · PubMed · doi:10.1164/arrd.1985.132.1.143 · Cited by 58
Goldstein, N., Lippmann, M. L., Goldberg, S. K., Fein, A. M., Shapiro, B., & Leon, S. A. (1985) · PubMed · doi:10.1164/arrd.1985.132.1.60 · Cited by 34
Karjalainen, A., Anttila, S. L., Heikkilä, L. J., Karhunen, P. J., & Vainio, H. (1993) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700230309 · Cited by 33
Vollmer, R. T., & Roggli, V. L. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80157-x · Cited by 15
Asbestos and the histogenesis of lung carcinoma.
Mark, E. J., & Shin, D.-H. (1992) · PubMed · Cited by 9
(1989) · PubMed
Cited by
Oxidative stress and pulmonary fibrosis
Cheresh, P., Kim, S.-J., Tulasiram, S., & Kamp, D. W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.021 · Cited by 530
The molecular basis of asbestos induced lung injury
Kamp, D. W., & Weitzman, S. A. (1999) · Thorax · doi:10.1136/thx.54.7.638 · Cited by 345
Asbestos-induced lung diseases: an update
Kamp, D. W. (2009) · Translational Research · doi:10.1016/j.trsl.2009.01.004 · Cited by 251
“p53 levels accumulate in lung cancers of patients with asbestosis.(71,72) Second, crocidolite asbestos promotes p53 gene mutations predominantly in exons 9 through 11 in BALB/c-3T3 cells.”
Molecular basis of asbestos-induced lung disease
Liu, G., Cheresh, P., & Kamp, D. W. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163942 · Cited by 213
Chronic inflammation and cancer: the role of the mitochondria.
Kamp, D. W., Shacter, E. B., & Weitzman, S. A. (2011) · PubMed · Cited by 243
Metadata
- Authors
- Nuorva, K., Mäkitaro, R., Huhti, E., Kamel, D., Vähäkangas, K., Bloigu, R., Soini, Y., & Pääkkö, P.
- Affiliations
- University of Oulu (FI)
- ORCID
- Bloigu, R
- Venue
- American journal of respiratory and critical care medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-08-01
- Volume
- 150
- Issue
- 2
- Pages
- 528-533
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2111850055
- Cited by
- 43
- References
- 31
- Citations by year
- 2024: 1 · 2020: 1 · 2019: 1 · 2014: 2 · 2013: 1 · 2012: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- p53 accumulation, lung cancer, asbestos exposure, smoking, asbestos bodies, TP53 mutation, tumor suppressor, occupational exposure, pack-years, lung carcinogenesis
- MeSH terms
- Aged, Asbestos, Female, Humans, Immunohistochemistry, Lung, Lung Neoplasms, Male, Middle Aged, Neoplasm Proteins, Smoking, Tumor Suppressor Protein p53, Occupational Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.